Hevolution Foundation and Dolby Family Ventures joined ND Capital as additional institutional investors bringing Series A funding in Vandria, advised by Walder Wyss, to a total of $30.7 million. Vandria’s lead CNS compound VNA-318 is
Hevolution Foundation and Dolby Family Ventures joined ND Capital as additional institutional investors bringing Series A funding in Vandria, advised by Walder Wyss, to a total of $30.7 million. Vandria’s lead CNS compound VNA-318 is